BackgroundCheck.run
Search For

Mark A Feinberg, 7812285 Portland Ave, Thiensville, WI 53092

Mark Feinberg Phones & Addresses

12285 Portland Ave, Thiensville, WI 53092    262-2435146   

Mequon, WI   

754 60Th St, Oakland, CA 94609    510-6554303   

339 Warwick Ave, Oakland, CA 94610    510-2688730   

1195 65Th St, Emeryville, CA 94608    510-6554303   

Alameda, CA   

Milwaukee, WI   

Pharr, TX   

Martinez, CA   

Ranks

Licence: New Jersey - Active Date: 1984

Mentions for Mark A Feinberg

Career records & work history

Lawyers & Attorneys

Mark Feinberg Photo 1

Mark Edward Feinberg - Lawyer

Licenses:
New Jersey - Active 1984

Mark Feinberg resumes & CV records

Resumes

Mark Feinberg Photo 46

Residential Remodeling

Location:
San Francisco, CA
Industry:
Consumer Goods
Work:
Mark Feinberg Carpentry and Remodeling
Residential Remodeling
Mark Feinberg Photo 47

Mark Feinberg

Mark Feinberg Photo 48

Mark Feinberg

Mark Feinberg Photo 49

Mark Feinberg

Mark Feinberg Photo 50

Mark Feinberg

Mark Feinberg Photo 51

Mark Feinberg

Mark Feinberg Photo 52

Mark Feinberg

Publications & IP owners

Us Patents

Replication-Competent Recombinant Viral Vaccines And Method Of Producing Same

US Patent:
5965124, Oct 12, 1999
Filed:
Jan 31, 1995
Appl. No.:
8/381637
Inventors:
Mark Feinberg - San Francisco CA
Raul Andino - New York NY
Patricia Anne Reilly - Glen Rock NJ
Assignee:
Whitehead Institute for Biomedical Research - Cambridge MA
American Cynamid Company - Parsippany NJ
International Classification:
A01N 6300
US Classification:
424 9321
Abstract:
Replication-competent recombinant viruses, particularly replication-competent recombinant polioviruses, which include (1) exogenous nucleic acid sequences which encode an exogenous polypeptide and (2) a nucleic acid sequence which encodes an artificial proteolytic cleavage site for a viral or cellular protease which proteolytically processes (cleaves) the precursor protein produced by the parent virus and uses therefor. The recombinant precursor is cleaved into the usual array of constituent proteins, freeing the exogenous polypeptide. Replication-competent recombinant viruses are useful as vaccines against bacterial, viral, fungal and yeast infections, parasitic diseases, cancer and allergies.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.